Insulinomas derived from hyperplastic intra-hepatic islet transplants

Area of Science:

• Endocrinology
• Oncology
• Animal Models

Background:

• Insulinomas are rare tumors of pancreatic beta cells.
• Current animal models for insulinoma development often involve genetic manipulation or chemical induction.
• A need exists for models that mimic spontaneous tumor development under specific metabolic conditions.

Purpose of the Study:

• To establish and characterize a new animal model for studying insulinoma development.
• To investigate the role of hyperglycemia and metabolic alterations in oncogenesis.
• To explore the potential of normal islet transplantation in inducing tumor formation.

Main Methods:

• Induction of diabetes in rats using streptozotocin.
• Transplantation of a low number of isologous pancreatic islets into the liver via the portal vein.
• Monitoring of glycemic control, islet cell hyperplasia, and tumor development over time.

Main Results:

• Low-number islet transplantation resulted in persistent hyperglycemia for over 13 months.
• Hyperglycemia stimulated hyperplasia of transplanted islet cells, particularly beta cells.
• Six out of 33 animals developed insulinomas from transplanted islets between 18-24 months, leading to severe hypoglycemia.
• Tumorigenesis occurred without DNA damage or transgenes, implicating metabolic factors.

Conclusions:

• Persistent hyperglycemia acts as a proliferative stimulus for beta cells, promoting insulinoma development.
• This model offers a unique platform to study oncogenesis driven by metabolic dysregulation.
• Metabolic alterations and sustained proliferative stimuli from hyperglycemia are critical factors in insulinoma formation in this model.